Signal From Noise

Gaining Through Weight Loss: The Opportunity for Investors as Ozempic, Mounjaro Tackle Obesity

“In two decades I've lost a total of 789 pounds. I should be hanging from a charm bracelet.” ~ Erma Bombeck

Obesity is a U.S. and global public-health problem. The global obesity rate has nearly doubled since 1980, and the World Health Organization estimates that nearly 1 billion people (adults, adolescents, and children) are obese. Some scientists project that by 2030, one in five women and one in seven men will be categorized as obese. Within the U.S., one in three adults is categorized as obese, and one in six children as well. (Obesity is officially defined as having a Body Mass Index of 30 or higher)

The video in this report is only accessible to members

Medical costs for people with obesity in the U.S. tend to be 30% to 40% higher than those for people without obesity – double the percentage attributable to cigarette smoking. Obesity accounts for 20% or more of the $4.5 trillion in annual U.S. healthcare expenditures – approximately $900 billion. 

While these statistics might not be common knowledge, the health consequences of obesity are. As a result, multiple sub-industries – specialty food, fitness, and supplements, for example – have arisen to help everyday men and women lose weight and improve their health – though climbing obesity rates suggest limited success.

That appears to have chan...

Unlock this article with a FREE 30-Day Trial!

An FSI Macro, FSI Crypto, FSI Pro, or FSI Weekly subscription is required in order to access this content.

*Free trial available only on a monthly plan

Disclosures (show)

Get invaluable analysis of the market and stocks. Cancel at any time. Start Free Trial

Articles Read 2/2

🎁 Unlock 1 extra article by joining our Community!

You’ve reached your limit of 2 free monthly articles. Please enter your email to unlock 1 more articles.

Already have an account? Sign In

Don't Miss Out
First Month Free